SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition

Vignesh Sundararajan, Ming Tan, Tuan Zea Tan, Jieru Ye, Jean Paul Thiery, Ruby Yun‐Ju HuangScientific 2019 · DOI

TL;DR

This study reveals a novel mechanism by which SNAI1, a key driver of cancer cell migration (EMT), actively suppresses the expression of its paralog, SNAI2. This repression is achieved through SNAI1's recruitment of histone deacetylase (HDAC) complexes to specific DNA sequences in the SNAI2 gene promoter, leading to a more "closed" chromatin structure and reduced gene transcription. This finding offers new therapeutic avenues by suggesting combined targeting of SNAI1 and HDACs for cancer treatment.

What Problem Does This Paper Address?

Epithelial-to-mesenchymal transition (EMT) is a fundamental biological process crucial for development but also implicated in cancer progression, metastasis, and therapeutic resistance. The SNAIL family of transcription factors, particularly SNAI1 and SNAI2, are known to be central players in orchestrating EMT. While both SNAI1 and SNAI2 are induced during EMT and associated with poor clinical outcomes, their precise regulatory relationship and the molecular mechanisms governing their interplay, especially in cancer, remain incompletely understood. Specifically, how SNAI1 might directly influence SNAI2 expression, and the epigenetic mechanisms involved, were not fully elucidated. This paper aims to unravel this regulatory axis, focusing on ovarian cancer.

Methods

The researchers employed a multi-pronged approach:

  • Ovarian Cancer Cell Line Panel (SGOCL): They analyzed a panel of 37 ovarian cancer cell lines representing different stages of the EMT spectrum to assess the correlation between SNAI1 and SNAI2 expression at both mRNA and protein levels.
  • Genetic Engineering: They created stable cell lines overexpressing SNAI1 (constitutively and inducibly) in an ovarian cancer cell line (OVCA429) to investigate the causal relationship between SNAI1 and SNAI2 expression.
  • Reporter Assays: Luciferase reporter assays were used to measure the transcriptional activity of the SNAI2 promoter and E-cadherin promoter (a known SNAI1 target) in cells with varying SNAI1 expression levels.
  • Chromatin Immunoprecipitation (ChIP-qPCR): This technique was used to identify specific DNA binding sites of SNAI1 within the SNAI2 promoter and to assess the enrichment of various histone modifications (e.g., H3K27Ac, H3K27me3, H3K4me3, H3K4me1) and corepressor proteins (HDAC1, HDAC2) at these sites.
  • Epigenetic Inhibitor Treatments: They treated SNAI1-overexpressing cells with inhibitors targeting histone deacetylases (HDACs), EZH2 (a histone methyltransferase), and DNMT1 (DNA methyltransferase) to determine which epigenetic machinery was involved in SNAI1-mediated SNAI2 repression.
  • Western Blotting and qRT-PCR: These standard molecular biology techniques were used to quantify protein and mRNA expression levels of SNAI1, SNAI2, and other EMT-related transcription factors (TWIST1, ZEB1/2).
  • Immunofluorescence Microscopy: Used to visualize cellular morphology and the expression patterns of epithelial (E-cadherin) and mesenchymal (Vimentin) markers.

Datasets

The study utilized an in-house panel of 37 ovarian cancer cell lines (SGOCL) for initial correlation analysis. Additionally, the lung adenocarcinoma cell line A549 was used to validate findings under TGF-β treatment. No new benchmark datasets were introduced.

Key Insights and Ideas

  • Mutually Exclusive Expression: A striking finding is the largely mutually exclusive expression of SNAI1 and SNAI2 in ovarian cancer cell lines, with SNAI1 predominantly found in epithelial-like cells and SNAI2 in more mesenchymal cells. This suggests a direct regulatory link.
  • SNAI1 Actively Represses SNAI2: The study moves beyond correlation to demonstrate that SNAI1 overexpression directly leads to a significant downregulation of SNAI2 expression, confirming a causal relationship.
  • HDAC Recruitment is Key: The most significant insight is the identification of SNAI1's mechanism of SNAI2 repression: it recruits histone deacetylase (HDAC) complexes, specifically HDAC1 and HDAC2, to the SNAI2 promoter.
  • Epigenetic Remodeling: This recruitment leads to a more condensed chromatin structure at the SNAI2 promoter, characterized by deacetylation of histone H3 and enrichment of repressive histone marks (H3K27me3), effectively silencing SNAI2 transcription.
  • Targeted Binding Sites: SNAI1 specifically binds to two E-box sequences within the SNAI2 promoter, acting as the anchor point for the repressive machinery.

Key Results

  • Negative Correlation: A statistically significant negative correlation (Rho = -0.3436, p=0.0229) was observed between SNAI1 and SNAI2 mRNA expression in the SGOCL panel.
  • SNAI1 Overexpression Suppresses SNAI2: Constitutive and inducible overexpression of SNAI1 in OVCA429 cells led to a marked decrease in SNAI2 protein and mRNA levels.
  • SNAI2 Promoter Repression: Luciferase reporter assays showed significantly reduced activity of the SNAI2 promoter in SNAI1-overexpressing cells compared to controls.
  • HDAC Inhibition Rescues SNAI2 Expression: Treatment with HDAC inhibitors (TSA and SAHA) partially restored SNAI2 expression in SNAI1-overexpressing cells, highlighting the critical role of HDACs.
  • HDAC Enrichment at SNAI2 Promoter: ChIP-qPCR confirmed significant enrichment of HDAC1 and HDAC2 at the SNAI1 binding sites (2' and 3' E-boxes) within the SNAI2 promoter in SNAI1-overexpressing cells.
  • Histone Modification Changes: SNAI1 overexpression led to deacetylation of H3K27Ac and increased H3K27me3 at the SNAI2 promoter E-box regions, indicative of transcriptional repression.

Limitations and Future Work

  • Direct Recruitment Evidence: While the study strongly implicates HDAC recruitment, direct evidence of SNAI1 physically interacting with HDAC complexes at the SNAI2 promoter would strengthen the findings. The authors acknowledge that further evidence is needed to elucidate whether HDACs are recruited directly or indirectly.
  • Other Corepressors: While HDACs appear to be the primary mediators, the partial rescue of SNAI2 expression by DNMT1 and EZH2 inhibitors suggests potential secondary roles for these pathways, which warrant further investigation.
  • Clinical Relevance of HDAC Inhibitors: The authors note that the heterogeneity of HDAC family member expression in ovarian cancer necessitates further investigation into the efficacy of HDAC inhibitors, alone or in combination with conventional chemotherapy, for treating ovarian cancer.
  • Patient Stratification: Identifying patients with SNAI1 and HDAC dependency during tumor progression is crucial for the effective use of HDAC inhibitors as therapeutics. This suggests a need for diagnostic markers.
  • Broader Cancer Types: While focused on ovarian cancer, exploring this regulatory mechanism in other cancer types where SNAI1 and SNAI2 are involved in EMT would be valuable.

Summary updated

Abstract

Aberrant activation of epithelial to mesenchymal transition (EMT) associated factors were highly correlated with increased mortality in cancer patients. SNAIL family of transcriptional repressors comprised of three members, each of which were essentially associated with gastrulation and neural crest formation. Among which, SNAI1 and SNAI2 were efficiently induced during EMT and their expressions were correlated with poor clinical outcome in patients with breast, colon and ovarian carcinoma. In an ovarian cancer cell lines panel, we identified that SNAI1 and SNAI2 expressions were mutually exclusive, where SNAI1 predominantly represses SNAI2 expression. Detailed analysis of SNAI2 promoter region revealed that SNAI1 binds to two E-box sequences that mediated transcriptional repression. Through epigenetic inhibitor treatments, we identified that inhibition of histone deacetylase (HDAC) activity in SNAI1 overexpressing cells partially rescued SNAI2 expression. Importantly, we demonstrated a significant deacetylation of histone H3 and significant enrichments of HDAC1 and HDAC2 corepressors in both E-box regions of SNAI2 promoter. Our results suggested that SNAI1 repression on SNAI2 expression was predominantly mediated through the recruitment of the histone deacetylation machinery. Utilization of HDAC inhibitors would require additional profiling of SNAI1 activity and combined targeting of SNAI1 and HDACs might render efficient cancer treatment.
BibTeX
@inproceedings{sundararajan2019snai,
  author = {Vignesh Sundararajan and Ming Tan and Tuan Zea Tan and Jieru Ye and Jean Paul Thiery and Ruby Yun‐Ju Huang},
  title = {{SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-44826-8},
}
Figure